#LCSM Transcript

Healthcare social media transcript of the #LCSM hashtag.
().
See #LCSM Influencers/Analytics.

Sign up for FREE Symplur Account and Get
  • Create Transcripts with Custom Dates
  • Get Custom Influencer Lists
  • 3x Hashtag Search Results
Sign Up Now
ProfileTweet
NCI Cancer Stats @NCICancerStats
Check out our map story on #LungCancer incidence, mortality, and smoking rates at the state and country level: https://t.co/wDxSFyFxAa #LCSM https://t.co/pPia4kP6vZ
Brendon Stiles @BrendonStilesMD
Hi #lcsm
Faces of Lung Cancer @LungCancerFaces
@BrendonStilesMD Hey Brendon! #lcsm
Brendon Stiles @BrendonStilesMD
Looking forward to a great chat about lung cancer at #ASCO18 #lcsm
Janet Freeman-Daily @JFreemanDaily
Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/QZHYZdw6aq
Janet Freeman-Daily @JFreemanDaily
Brendon! Glad you're able to join us. I'll need help explaining some of these abstracts! @BrendonStilesMD #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/…
Faces of Lung Cancer @LungCancerFaces
RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/…
Brendon Stiles @BrendonStilesMD
@JFreemanDaily I will give it my best shot! At least for the early stage! #lcsm
Faces of Lung Cancer @LungCancerFaces
Deana Hendrickson in Los Angeles here. Look forward to chatting about #ASCO18 lung cancer. #lcsm
Karen Loss @cancertrek
Hi everyone. Karen here. #lcsm
Janet Freeman-Daily @JFreemanDaily
If' you're listening, please tweet #LCSM so we'll know who'se in the audience
Brendon Stiles @BrendonStilesMD
I think #LungCancer will be hot again at #ASCO18 #lcsm
Faces of Lung Cancer @LungCancerFaces
@cancertrek Hi Karen! How are you? #lcsm
Janet Freeman-Daily @JFreemanDaily
@cancertrek Hey Karen! #lcsm
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD Indeed -- several hot abstracts on @JackWestMD's lists this year. #lcsm
Anita Figueras @scifiknitter
RT @JFreemanDaily: Welcome to #LCSM Chat! Tonight’s topic is “Lung Cancer at ASCO 2018.” A brief overview is available here: https://t.co/…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: If' you're listening, please tweet #LCSM so we'll know who'se in the audience
Faces of Lung Cancer @LungCancerFaces
RT @JFreemanDaily: If' you're listening, please tweet #LCSM so we'll know who'se in the audience
Anita Figueras @scifiknitter
Anita here! #LCSM
Faces of Lung Cancer @LungCancerFaces
@scifiknitter Hi Anita! #lcsm
Janet Freeman-Daily @JFreemanDaily
We'll get started in a few minutes -- please take a moment to introduce yourselves #lcsm
Janet Freeman-Daily @JFreemanDaily
I’m your moderator Janet Freeman-Daily: writer (https://t.co/OBCc88h7Jg), science geek, stage IV #lungcancer patient/activist #lcsm
Brendon Stiles @BrendonStilesMD
@scifiknitter Hi Anita! #lcsm
Janet Freeman-Daily @JFreemanDaily
If you are new to Twitter chats and/or #LCSM Chat, you might find our primer on how to participate helpful https://t.co/5g28sSzfTD
Geri Massa @GeriGerim13
Good Evening All Can someone send me the link to be able chat, I don’t know the name of it .. you can watch and seethe chat rather than refreshing for new posts If I make any sense, lol #LCSM
Anita Figueras @scifiknitter
@LungCancerFaces Hi Deana! #lcsm
Janet Freeman-Daily @JFreemanDaily
This chat will be a different format than usual--we'll be posting & discussing abstracts from the upcoming #ASCO18 annual meeting #lcsm
Brendon Stiles @BrendonStilesMD
Brendon Stiles here...thoracic surgeon, researcher, seeking clarity from abstracts, which is always a challenge! #lcsm
Anita Figueras @scifiknitter
@BrendonStilesMD Hi Brendon! Thanks for helping us understand these abstracts. #lcsm
#LCSM Chat @lcsmchat
@GeriGerim13 Hi Geri! Try https://t.co/REUOM3GZHV #lcsm
Janet Freeman-Daily @JFreemanDaily
I know @scifiknitter, @cancertrek, @BrendonStilesMD and @lungcancerfaces all know what @ASCO is-- anyone need an overview? #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: This chat will be a different format than usual--we'll be posting & discussing abstracts from the upcoming #ASCO18 annua…
LungCancer.net @LungCancer_HU
Hi! Margot here #lcsm
Lecia Sequist, MD, MPH @LeciaSequist
Hey #LCSM, welcome rad Onc doc extraordinaire @HenningWillers to twitter!!
#LCSM Chat @lcsmchat
RT @JFreemanDaily: I know @scifiknitter, @cancertrek, @BrendonStilesMD and @lungcancerfaces all know what @ASCO is-- anyone need an overvie…
Faces of Lung Cancer @LungCancerFaces
@LeciaSequist @HenningWillers Welcome! #lcsm
Karen Loss @cancertrek
@LungCancer_HU Hi Margot! #lcsm
Brendon Stiles @BrendonStilesMD
@LeciaSequist @HenningWillers Thanks to both of you for joining! #lcsm
Faces of Lung Cancer @LungCancerFaces
@LungCancer_HU Hey Margot! #lcsm
LungCancer.net @LungCancer_HU
@cancertrek hi! #lcsm
#LCSM Chat @lcsmchat
RT @LeciaSequist: Hey #LCSM, welcome rad Onc doc extraordinaire @HenningWillers to twitter!!
Anita Figueras @scifiknitter
@LungCancer_HU Hey Margot! #lcsm
LungCancer.net @LungCancer_HU
@LungCancerFaces hey!! #lcsm
LungCancer.net @LungCancer_HU
@scifiknitter hi Anita! #lcsm
Janet Freeman-Daily @JFreemanDaily
Let's get started! @BrendonStilesMD , do you have any abstracts you'd like to discuss? #LCSM
KC Dill @kasedill
Hello from Texas how is everyone? #lcsm
OncLive.com @OncLive
Adding atezolizumab to nab-paclitaxel and carboplatin in the frontline setting significantly improved OS in patients with advanced NSCLC, according to findings from the phase III IMpower130 study #lcsm https://t.co/GzhSEs26ld
Faces of Lung Cancer @LungCancerFaces
@kasedill Howdy! Thanks for joining. #lcsm
Anita Figueras @scifiknitter
@LeciaSequist @HenningWillers Hello @LeciaSequist & @HenningWillers. Looking forward to your insights. #lcsm
Brendon Stiles @BrendonStilesMD
Well...I like the concept of 8502 regarding the importance of lymph node dissection in earlier stage. Not sure I believe the "kit" makes the difference, but we not surgical quality matters. #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Let's get started! @BrendonStilesMD , do you have any abstracts you'd like to discuss? #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Well...I like the concept of 8502 regarding the importance of lymph node dissection in earlier stage. Not sure I beli…
Brendon Stiles @BrendonStilesMD
And of course, since @henningWillers is here, I am happy to talk about 8511 showing inferiority of SBRT to surgery for matched early stage patients (with caveats) and the update of 8512 showing high SBRT failure rates! Sorry - couldn't help it. #lcsm
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD Please translate: what does "lymph node dissection" mean? #LCSM
Karen Loss @cancertrek
@JFreemanDaily @BrendonStilesMD Paging Dr. Stiles. ;) #lcsm
#LCSM Chat @lcsmchat
@BrendonStilesMD Brendon, can you break your tweet above into two tweets. Doesn't show up in tchat because it's over 140. #lcsm
Friends of Ernie @ErniesLibrary
#adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/LowKv2yy8w
Brendon Stiles @BrendonStilesMD
8512 is important. Shows long term treatment failure, either loco regional or metastatic recurrence in 27/65 stage IA patients after SBRT - although dose slightly lower than that used now. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: And of course, since @henningWillers is here, I am happy to talk about 8511 showing inferiority of SBRT to surgery for…
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @BrendonStilesMD Please translate: what does "lymph node dissection" mean? #LCSM
Stephen Ramey @StephenRameyMD
RT @natlestercoll: @NRGonc 0618 shows 96% local control at 4 years for operable T1-T2 peripheral NSCLC treated with SBRT #radonc #lcsm http…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: 8512 is important. Shows long term treatment failure, either loco regional or metastatic recurrence in 27/65 stage IA…
Brendon Stiles @BrendonStilesMD
Lymph node dissection - important for surgeons to remove nodes. #lcsm
Brendon Stiles @BrendonStilesMD
Node removal is important for accurate staging and is quality indicator. #lcsm
Karen Loss @cancertrek
RT @BrendonStilesMD: Node removal is important for accurate staging and is quality indicator. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Lymph node dissection - important for surgeons to remove nodes. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Node removal is important for accurate staging and is quality indicator. #lcsm
Brendon Stiles @BrendonStilesMD
This is from 8502 using a kit to improve node counting. #lcsm
Dr Riyaz Shah @DrRiyazShah
@lindacoate @n8pennell #LCSM will give it a go
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD Since most of the people in this chat are patients rather than surgeons, can you tell us the findings of the abstract? #lcsm
Brendon Stiles @BrendonStilesMD
8511 is surgery vs. SBRT for early cancer. #lcsm
Faces of Lung Cancer @LungCancerFaces
@DrRiyazShah Welcome! You'll be fine. Promise. @lindacoate @n8pennell #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: This is from 8502 using a kit to improve node counting. #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @BrendonStilesMD Since most of the people in this chat are patients rather than surgeons, can you tell us the findings o…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: 8511 is surgery vs. SBRT for early cancer. #lcsm
Brendon Stiles @BrendonStilesMD
@LeciaSequist - what do you think of ARCHER 1050? Where do we use newer EGFR TKIs? #lcsm
Faces of Lung Cancer @LungCancerFaces
RT @BrendonStilesMD: @LeciaSequist - what do you think of ARCHER 1050? Where do we use newer EGFR TKIs? #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @LeciaSequist - what do you think of ARCHER 1050? Where do we use newer EGFR TKIs? #lcsm
Brendon Stiles @BrendonStilesMD
@HenningWillers What do you make of the JCOG study, abstract 8512, showing long term results with SBRT? #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @HenningWillers What do you make of the JCOG study, abstract 8512, showing long term results with SBRT? #lcsm
Brendon Stiles @BrendonStilesMD
Also like Jack point out 8501. Blood tests will continue to advance into clinical care. #lcsm
Janet Freeman-Daily @JFreemanDaily
FYI, here is @jackwestmd's list of Top 5 #ASCO19 abstracts for #lungcancer #LCSM https://t.co/aBY8RJKm37 https://t.co/MVxeGzP3ow
Geri Massa @GeriGerim13
#lcsm I am assuming the numbers mentioned are different genetic cell identifiers ? Topic I’m not familiar with Thanks 😀
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Also like Jack point out 8501. Blood tests will continue to advance into clinical care. #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: FYI, here is @jackwestmd's list of Top 5 #ASCO19 abstracts for #lungcancer #LCSM https://t.co/aBY8RJKm37 https://t.co/MV…
Brendon Stiles @BrendonStilesMD
@JFreemanDaily Basically - shows importance of quality control in surgery. #lcsm
Brendon Stiles @BrendonStilesMD
Lots of combo-immunotherapy trials, based on concept that chemo-IO may complement each other. #lcsm
Henning Willers, MD @HenningWillers
@BrendonStilesMD @BrendonStilesMD Good to be here! Long awaited data, showing promise. However I do not buy (quite yet) into the notion that SBRT can compete with anatomical resection in operable patient #lcsm
Faces of Lung Cancer @LungCancerFaces
@GeriGerim13 The numbers on Jack's list are assigned by ASCO. They have no meaning beyond being identifiers for each abstract. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @JFreemanDaily Basically - shows importance of quality control in surgery. #lcsm
Geri Massa @GeriGerim13
Names of trials ? #LCSM
Montessa M. Lee @MontessaLee
RT @ivybelkins: Heading to #ASCO18 soon! @jillfeldman4 and I will be representing the @EGFRResisters and we look forward to checking out s…
Montessa M. Lee @MontessaLee
RT @jillfeldman4: On our way to #ASCO18. Looking forward to @EGFRResisters inaugural Think Tank with @jfowlerpharmd. @ivybelkins and I will…
Brendon Stiles @BrendonStilesMD
@HenningWillers Totally fair and I appreciate the "quite yet"! Good to see you here on twitter. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Lots of combo-immunotherapy trials, based on concept that chemo-IO may complement each other. #lcsm
#LCSM Chat @lcsmchat
RT @HenningWillers: @BrendonStilesMD @BrendonStilesMD Good to be here! Long awaited data, showing promise. However I do not buy (quite yet)…
Brendon Stiles @BrendonStilesMD
@HenningWillers One more #RadOnc for me to learn from! #lcsm
Henning Willers, MD @HenningWillers
@BrendonStilesMD Generally, distant failure rates in stage I patients treated with surgery or SBRT are comparable (15-20%) #lcsm
Brendon Stiles @BrendonStilesMD
@GeriGerim13 KEYNOTE 024 and 407, IMPOWER 131, CHECKMATE 227 #lcsm
Janet Freeman-Daily @JFreemanDaily
@GeriGerim13 Geri--some clinical trials have memorable names, but that's independent of the abstract number assigned by @ASCO for a meeting. #LCSM
#LCSM Chat @lcsmchat
Hi @peggyddennis! Glad to see you. #lcsm
Brendon Stiles @BrendonStilesMD
@GeriGerim13 Keep your eye out for news updates about these. May extend groups of patients who benefit from IO. #lcsm
Matthias Scheffler @trnsltnl
@JFreemanDaily @JackWestMD Totally looking forward to seeing the Keynote-042 results. And of course ARCHER, still not convinced that Osimertinib upfront might be the best choice for EGFR-driven cancers. #LCSM @EGFRResisters
Janet Freeman-Daily @JFreemanDaily
@HenningWillers @BrendonStilesMD Hi Henning--glad you dropped in to #LCSM Chat!
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @GeriGerim13 KEYNOTE 024 and 407, IMPOWER 131, CHECKMATE 227 #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @GeriGerim13 Keep your eye out for news updates about these. May extend groups of patients who benefit from IO. #lcsm
#LCSM Chat @lcsmchat
RT @trnsltnl: @JFreemanDaily @JackWestMD Totally looking forward to seeing the Keynote-042 results. And of course ARCHER, still not convinc…
Brendon Stiles @BrendonStilesMD
@LeciaSequist @TonyMok9 Well said. Important study for sure and more hope for #EGFR patients. #lcsm
Janet Freeman-Daily @JFreemanDaily
I'll be very interested to see IMPOWER150 results to see if chemo+immunotherapy might be helpful for NSCLC with genomic drivers. #LCSM
Faces of Lung Cancer @LungCancerFaces
Chatters, please note that although twitter allows for 280 characters, most tweet chat tools only allow for 140, so keep it short, pls #lcsm
#LCSM Chat @lcsmchat
#lcsm https://t.co/irhiTJxXxd
#LCSM Chat @lcsmchat
RT @JFreemanDaily: I'll be very interested to see IMPOWER150 results to see if chemo+immunotherapy might be helpful for NSCLC with genomic…
Henning Willers, MD @HenningWillers
@BrendonStilesMD Good study!! Not clear to me how many patients had lobectomy. Again I do not think that SBRT can compete with lobectomy, but other long-term data show that local failure after SBRT is comparable to wedge and thus SBRT good option for elderly high risk population. #lcsm
#LCSM Chat @lcsmchat
RT @LungCancerFaces: Chatters, please note that although twitter allows for 280 characters, most tweet chat tools only allow for 140, so ke…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: @GeriGerim13 Keep your eye out for news updates about these. May extend groups of patients who benefit from IO. #lcsm
Brendon Stiles @BrendonStilesMD
@LungCancerFaces OK #lcsm
Timothy Craig Allen @TimAllenMDJD
RT @JFreemanDaily: FYI, here is @jackwestmd's list of Top 5 #ASCO19 abstracts for #lungcancer #LCSM https://t.co/aBY8RJKm37 https://t.co/MV…
Brendon Stiles @BrendonStilesMD
Get it? @LungCancerFaces #lcsm
Janet Freeman-Daily @JFreemanDaily
@LeciaSequist @TonyMok9 Lecia! So glad to see you on #LCSM Chat. Please remember to include #LCSM in your tweets so your post will show up in the feed.
#LCSM Chat @lcsmchat
RT @HenningWillers: @BrendonStilesMD Good study!! Not clear to me how many patients had lobectomy. Again I do not think that SBRT can compe…
Brendon Stiles @BrendonStilesMD
@HenningWillers Maybe...I still quibble with definition of "long term" in SBRT literature. #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @LeciaSequist @TonyMok9 Lecia! So glad to see you on #LCSM Chat. Please remember to include #LCSM in your tweets so you…
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD @LungCancerFaces Yes, I see you! :) #LCSM
#LCSM Chat @lcsmchat
Thanks for joining! #lcsm https://t.co/zeAqVraV0F
Brendon Stiles @BrendonStilesMD
Will be nice to see if IO + chemo works for patients w/ PDL1<1% in CHECKMATE 227 #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @HenningWillers Maybe...I still quibble with definition of "long term" in SBRT literature. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Will be nice to see if IO + chemo works for patients w/ PDL1<1% in CHECKMATE 227 #lcsm
KC Dill @kasedill
If your tumor wan not genetically tested and you had a complete response to IO how does a person determine if there is a mutation present? A little off topic but I am curious. #lcsm
Brendon Stiles @BrendonStilesMD
Here is ARCHER1050 news release https://t.co/uPNQgRvMTd #lcsm
#LCSM Chat @lcsmchat
RT @kasedill: If your tumor wan not genetically tested and you had a complete response to IO how does a person determine if there is a muta…
Janet Freeman-Daily @JFreemanDaily
#ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "value" will also be big. #LCSM
Anita Figueras @scifiknitter
@BrendonStilesMD Is this a case where we patients should be even more concerned with OS than PFS? #LCSM
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: Here is ARCHER1050 news release https://t.co/uPNQgRvMTd #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Here is ARCHER1050 news release https://t.co/uPNQgRvMTd #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: #ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "…
#LCSM Chat @lcsmchat
RT @scifiknitter: @BrendonStilesMD Is this a case where we patients should be even more concerned with OS than PFS? #LCSM
Henning Willers, MD @HenningWillers
@BrendonStilesMD 5-year local failure rates after SBRT in 3 prospective trials (RTOG x 2 and MDACC) are 7-8%, which is not bad! Criticism from surgeons has been that some local failures may still hide behind radiation fibrosis. Time will tell. #lcsm
Friends of Ernie @ErniesLibrary
#adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/qwBFV2icAa https://t.co/JNM9FRidQr
Brendon Stiles @BrendonStilesMD
Here is @jackwest list https://t.co/rk5lsKSDU4 #lcsm
#LCSM Chat @lcsmchat
Welcome, Michelle. #LCSM https://t.co/5Fl4ORodcC
Timothy Craig Allen @TimAllenMDJD
RT @JFreemanDaily: #ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "…
#LCSM Chat @lcsmchat
RT @HenningWillers: @BrendonStilesMD 5-year local failure rates after SBRT in 3 prospective trials (RTOG x 2 and MDACC) are 7-8%, which is…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Here is @jackwest list https://t.co/rk5lsKSDU4 #lcsm
Brendon Stiles @BrendonStilesMD
@scifiknitter We should always be more concerned with OS than PFS!!! Although there is value in PFS #lcsm
Janet Freeman-Daily @JFreemanDaily
@kasedill If you had a complete response to immunotherapy, does it matter if your cancer has a driving mutation? You can test it later **IF** your cancer returns. #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @scifiknitter We should always be more concerned with OS than PFS!!! Although there is value in PFS #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @kasedill If you had a complete response to immunotherapy, does it matter if your cancer has a driving mutation? You can…
Anita Figueras @scifiknitter
RT @BrendonStilesMD: @scifiknitter We should always be more concerned with OS than PFS!!! Although there is value in PFS #lcsm
Matthias Scheffler @trnsltnl
CR is CR, no matter which rationale was used! #LCSM Totally agree with @JFreemanDaily https://t.co/UwMJ6CKsjF
Janet Freeman-Daily @JFreemanDaily
Nice that this #LCSM Chat is slower than usual. If you think following a fast-pace tweetchat is tough, ASCO is like being run over on a speedway.
#LCSM Chat @lcsmchat
RT @trnsltnl: CR is CR, no matter which rationale was used! #LCSM Totally agree with @JFreemanDaily https://t.co/UwMJ6CKsjF
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Nice that this #LCSM Chat is slower than usual. If you think following a fast-pace tweetchat is tough, ASCO is like bein…
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD @jackwest Thank you, @BrendonStilesMD. My PC and I are having a disagreement about whether I should be able to see #LCSM Chat's tweet.
Brendon Stiles @BrendonStilesMD
Here is 8512. Would have made plenary session at surgical meeting! https://t.co/6DlljTUhsf #lcsm
Faces of Lung Cancer @LungCancerFaces
I see you Steve! @dark_hawk_98 #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @BrendonStilesMD @jackwest Thank you, @BrendonStilesMD. My PC and I are having a disagreement about whether I should be…
Anita Figueras @scifiknitter
@JFreemanDaily An example: @n8pennell's analysis that NGS testing at diagnosis would save money overall. #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Here is 8512. Would have made plenary session at surgical meeting! https://t.co/6DlljTUhsf #lcsm
#LCSM Chat @lcsmchat
RT @scifiknitter: @JFreemanDaily An example: @n8pennell's analysis that NGS testing at diagnosis would save money overall. #LCSM
Henning Willers, MD @HenningWillers
@BrendonStilesMD It does make it difficult to compare pT1/2 N0 population (which has the cN0pN1/2 patients removed) to clinicaly staged SBRT cohorts. Generally, nodal failure rates after SBRT are lower than one would expect from surgical literature (<10%) #lcsm
Janet Freeman-Daily @JFreemanDaily
Hey @TimAllenMDJD , any cool #ASCO18 abstracts about pathology? #LCSM
#LCSM Chat @lcsmchat
RT @HenningWillers: @BrendonStilesMD It does make it difficult to compare pT1/2 N0 population (which has the cN0pN1/2 patients removed) to…
Timothy Craig Allen @TimAllenMDJD
RT @JFreemanDaily: @kasedill If you had a complete response to immunotherapy, does it matter if your cancer has a driving mutation? You can…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: Here is @jackwest list https://t.co/rk5lsKSDU4 #lcsm
Brendon Stiles @BrendonStilesMD
Here is the one about lymph nodes. https://t.co/4i872uuWq7 #lcsm
Janet Freeman-Daily @JFreemanDaily
@scifiknitter @n8pennell Yes! Thanks for pointing that out, Anita. #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: Hey @TimAllenMDJD , any cool #ASCO18 abstracts about pathology? #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Here is the one about lymph nodes. https://t.co/4i872uuWq7 #lcsm
Michelle Burrus @saiwoman2
#LCSM
Brendon Stiles @BrendonStilesMD
@HenningWillers Very true. This again demonstrates critical importance of nodal staging. #lcsm
Laura Greco @lgreco_ny
Laura here late. Asco here I come! #lcsm
Brendon Stiles @BrendonStilesMD
@HenningWillers Got to pick right patients and EBUS those with any possible N1/N2. #lcsm
Janet Freeman-Daily @JFreemanDaily
RT @BrendonStilesMD: Here is 8512. Would have made plenary session at surgical meeting! https://t.co/6DlljTUhsf #lcsm
Timothy Craig Allen @TimAllenMDJD
Thanks for asking, @JFreemanDaily I'm sure there are! Unfortunately I will not be able to attend this one... #Boston #lcsm https://t.co/JRd2IkuitX
Laura Greco @lgreco_ny
RT @JFreemanDaily: I'll be very interested to see IMPOWER150 results to see if chemo+immunotherapy might be helpful for NSCLC with genomic…
Timothy Craig Allen @TimAllenMDJD
RT @BrendonStilesMD: Here is the one about lymph nodes. https://t.co/4i872uuWq7 #lcsm
Faces of Lung Cancer @LungCancerFaces
@saiwoman2 Welcome! #lcsm
Faces of Lung Cancer @LungCancerFaces
@lgreco_ny Hey! Better late than never. #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @HenningWillers Very true. This again demonstrates critical importance of nodal staging. #lcsm
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @HenningWillers Got to pick right patients and EBUS those with any possible N1/N2. #lcsm
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Thanks for asking, @JFreemanDaily I'm sure there are! Unfortunately I will not be able to attend this one... #Boston #…
Brendon Stiles @BrendonStilesMD
Ask @TimAllenMDJD how important this is! #lcsm
Janet Freeman-Daily @JFreemanDaily
@lgreco_ny Hey Laura! Have you built your #ASCO18 schedule yet? #LCSM
Laura Greco @lgreco_ny
RT @JFreemanDaily: @lgreco_ny Hey Laura! Have you built your #ASCO18 schedule yet? #LCSM
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: Ask @TimAllenMDJD how important this is! #lcsm
Laura Greco @lgreco_ny
@JFreemanDaily I did last week, although I'm sure I'll change it. #lcsm
Janet Freeman-Daily @JFreemanDaily
@TimAllenMDJD When will you be in #BOSTON? I'll be there starting 6/9-10. #LCSM
Brendon Stiles @BrendonStilesMD
I am missing #ASCO18. Will follow on #SoMe. Too tired from Ljubljana! #lcsm
Tips for Diabetes @diabetic_li
RT @DrSadhanaJ: And even second hand #smoking can cause toxic long term effects to #children. Let’s encourage a #healthyliving and #polluti
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters for some sessions this year! #LCSM
Tessa Sheldon @tessa_perrin
Swinging by.... #lcsm
Laura Greco @lgreco_ny
@JFreemanDaily Ugh! #lcsm
Brendon Stiles @BrendonStilesMD
@lcsmchat Just got back from Slovenia! #26ests @thoracic #lcsm
#LCSM Chat @lcsmchat
RT @JFreemanDaily: @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters f…
Timothy Craig Allen @TimAllenMDJD
Big step forward IMHO. Critical to get it right every time. #PatientsFirst #lcsm https://t.co/lyPOUYeTjF
Brendon Stiles @BrendonStilesMD
RT @JFreemanDaily: @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters f…
H. Jack West, MD @JackWestMD
RT @JAMAOnc: Calculations based on FLAURA trial of #osimertinib vs first gen #EGFR TKIs reveals incremental cost-effectiveness ratio for os…
Faces of Lung Cancer @LungCancerFaces
@tessa_perrin Hey, Tessa! Good to see you. #lcsm
Brendon Stiles @BrendonStilesMD
RT @TimAllenMDJD: Big step forward IMHO. Critical to get it right every time. #PatientsFirst #lcsm https://t.co/lyPOUYeTjF
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @lcsmchat Just got back from Slovenia! #26ests @thoracic #lcsm
a muse @_a_muse
RT @JAMAOnc: Calculations based on FLAURA trial of #osimertinib vs first gen #EGFR TKIs reveals incremental cost-effectiveness ratio for os…
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: Big step forward IMHO. Critical to get it right every time. #PatientsFirst #lcsm https://t.co/lyPOUYeTjF
Anita Figueras @scifiknitter
@JFreemanDaily @BrendonStilesMD Janet, how does one find info on the real time sessions? #LCSM
Matthias Scheffler @trnsltnl
@BrendonStilesMD I am missing too, but #SoMe had helped me so much over the last years. Too tired, as well! #LCSM
#LCSM Chat @lcsmchat
RT @scifiknitter: @JFreemanDaily @BrendonStilesMD Janet, how does one find info on the real time sessions? #LCSM
#LCSM Chat @lcsmchat
RT @trnsltnl: @BrendonStilesMD I am missing too, but #SoMe had helped me so much over the last years. Too tired, as well! #LCSM
Henning Willers, MD @HenningWillers
@BrendonStilesMD and trust a negative EBUS ... just to reiterate though, nodal failure rates -it seems to me- are lower than would be expected (absent surgical nodal assessment) - radiation may have effect on microscopic nodal disease. incident dose? abscopal effect? #lcsm
Lung Cancer Sux @LungCancerSux
RT @JFreemanDaily: @BrendonStilesMD Looking forward to following #ASCO18 on #SoMe (social media) AND on app--real-time slides and posters f…
Liz Highleyman @LizCancerHealth
RT @JFreemanDaily: #ASCO18 will cover a lot of topics of interest to #lungcancer besides drugs, surgery, and radiation. Patient care, and "…
Bob Steele @steele_bob
Better late than never,,, #lcsm
#LCSM Chat @lcsmchat
RT @HenningWillers: @BrendonStilesMD and trust a negative EBUS ... just to reiterate though, nodal failure rates -it seems to me- are lower…
Timothy Craig Allen @TimAllenMDJD
2d through 6th. Wish we overlapped; would be great to visit with you! #lcsm https://t.co/CiIyEAkrnD
Yonemoto N @nyonenyone
RT @JAMAOnc: Calculations based on FLAURA trial of #osimertinib vs first gen #EGFR TKIs reveals incremental cost-effectiveness ratio for os…
Brendon Stiles @BrendonStilesMD
Signing off everyone. Have a great #ASCO18. Soak it all in, but ask the tough questions too! #lcsm
Janet Freeman-Daily @JFreemanDaily
I'm missing ASCO this year because I have three other trips and presentations in June, and did #AACR18 in April. I too get tired of travel. #LCSM
Faces of Lung Cancer @LungCancerFaces
@steele_bob Bob! How are you, my friend? #lcsm
#LCSM Chat @lcsmchat
RT @TimAllenMDJD: 2d through 6th. Wish we overlapped; would be great to visit with you! #lcsm https://t.co/CiIyEAkrnD
Bob Steele @steele_bob
slowly better, thanks #lcsm
Faces of Lung Cancer @LungCancerFaces
@BrendonStilesMD So long, Brendon! #LCSM
#LCSM Chat @lcsmchat
RT @JFreemanDaily: I'm missing ASCO this year because I have three other trips and presentations in June, and did #AACR18 in April. I too g…
Friends of Ernie @ErniesLibrary
#adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/XCjpwarEZL
Brendon Stiles @BrendonStilesMD
@HenningWillers I concede there probably is some radio-immune effect. I think many problems are result of poor staging or poor selection. #lcsm
Anita Figueras @scifiknitter
@steele_bob Super glad to hear this, Bob! #LCSM
Anita Figueras @scifiknitter
@BrendonStilesMD Thanks Brendon! #LCSM
Timothy Craig Allen @TimAllenMDJD
#LikeABoss #lcsm https://t.co/DuK4qdAuCn
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @HenningWillers I concede there probably is some radio-immune effect. I think many problems are result of poor stagin…
Janet Freeman-Daily @JFreemanDaily
I'm ending this #LCSM chat a bit early tonight--I have a presentation I MUST finish. Sorry for the short notice. Thanks everyone for joining!
Matthias Scheffler @trnsltnl
Same for the future of oncology and the new generation of oncologists! #LCSM https://t.co/aAiEZNHrYL
KC Dill @kasedill
Goodnight all I enjoyed the information #lcsm
Janet Freeman-Daily @JFreemanDaily
@BrendonStilesMD Thanks for participating tonight! Someday I'd love to hear about Slovenia trip. #LCSM
#LCSM Chat @lcsmchat
RT @JFreemanDaily: I'm ending this #LCSM chat a bit early tonight--I have a presentation I MUST finish. Sorry for the short notice. Thanks…
#LCSM Chat @lcsmchat
RT @trnsltnl: Same for the future of oncology and the new generation of oncologists! #LCSM https://t.co/aAiEZNHrYL
Janet Freeman-Daily @JFreemanDaily
@scifiknitter @BrendonStilesMD I registered for the conference so I could access the content. #LCSM
Anita Figueras @scifiknitter
@JFreemanDaily Thanks, Janet! #LCSM
Faces of Lung Cancer @LungCancerFaces
'Night everyone! Thanks for moderating tonight @JFreemanDaily #lcsm
Anita Figueras @scifiknitter
@JFreemanDaily @BrendonStilesMD Attending from the comfort of your home, with informed commentary from your cat - there are worse ways to attend a conference. #LCSM
Liz Highleyman @LizCancerHealth
@JFreemanDaily @scifiknitter @BrendonStilesMD ASCO did this at their smaller #ImmunoOnc18 and other specialty meetings this year -- it was great! #LCSM
Friends of Ernie @ErniesLibrary
#adcsm #ancsm #bcsm #blcsm #btsm #crcsm #esophca #gynca #hpbcsm #hncsm #krcc #lcsm #lylsm #melnm #pancsm #pcsm #srcma #stomca #testca #thymca https://t.co/XCjpwarEZL https://t.co/Sd2pBRVuZ2
#LCSM content from Twitter.